Provided by Tiger Trade Technology Pte. Ltd.

Cyteir Therapeutics

3.02
0.0000
Volume:- -
Turnover:3.04M
Market Cap:108.69M
PE:-3.23
High:3.02
Open:3.02
Low:3.02
Close:3.02
52wk High:3.19
52wk Low:1.43
Shares:35.99M
Float Shares:10.83M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9344
EPS(LYR):-1.3058
ROE:-23.80%
ROA:-14.50%
PB:0.87
PE(LYR):-2.31

Loading ...

Company Profile

Company Name:
Cyteir Therapeutics
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the oncology therapeutics. Its lead product CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. Cyteir Therapeutics, Inc. was incorporated in 2012 and is headquartered in Lexington, Massachusetts.